September 29, 2022 eCOA Consortium Announces New Article for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Evaluating the Use of Backup Solutions for ePRO Systems” has been publ
September 27, 2022 Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation Board names Dr. Daniel Jorgensen as Chief Executive Officer TUCSON, Ariz., Sept. 27, 2022 — Critical Path Institute (C-Path) tod
September 22, 2022 View Now: Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership C-Path’s Transplant Therapeutics Consortium (TTC), in collaboration with key opinion leaders from academic institutions, the pha
September 21, 2022 Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports
September 20, 2022 C-Path’s European Nonprofit Appoints Managing Director and New Board Member to Expand Global Efforts TUCSON, Ariz. and AMSTERDAM, September 20, 2022 — Critical Path Institute’s (C-Path) European nonprofit today announced the ap
September 15, 2022 Rare Disease Workshop Highlights the Importance of Data Sharing in Drug Development C-Path, NORD and FDA hosted an annual workshop September 13-14 to spotlight the impact of their innovative data and analytics plat
September 14, 2022 C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases TUCSON, Ariz., Sept. 14, 2022 — Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Pat
September 13, 2022-September 14, 2022 View Now | 2022 RDCA-DAP Workshop, September 13-14 Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i
September 8, 2022 C-Path’s Kristen Swingle Named President Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-
September 7, 2022 Evaluating the Use of Backup Solutions for ePRO Systems has been published in Applied Clinical Trials